L & S Advisors Inc Exact Sciences Corp Transaction History

L & S Advisors Inc

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 13, 2023	BUY	$65.94 - $99.04 $394,387 - $592,358	5,981 Added 68.29%	14,739 $1.01 Million
Q2 2023 Aug 11, 2023	BUY	$62.68 - $95.05 $548,951 - $832,447	8,758 New	8,758 $822,000
Q3 2019 Nov 14, 2019	SELL	$90.37 - $122.49 $1.58 Million - $2.15 Million	-17,530 Closed	0 $0
Q2 2019 Aug 13, 2019	SELL	$89.51 - $118.04 $23,451 - $30,926	-262 Reduced 1.47%	17,530 $2.07 Million
Q1 2019 May 14, 2019	BUY	$61.98 - $96.5 $1.1 Million - $1.72 Million	17,792 New	17,792 $1.54 Million

676

162M

2.58M

2.19M

Ticker EXAS
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 176,960,000
Market Cap $10.1B
Description
Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...

Get notified when there are updates to the investment portfolio of L & S Advisors Inc, based on Form 13F filings with the SEC.

Stay updated on L & S Advisors Inc with notifications on news.